The McGowan Institute for Regenerative Medicine, affiliated with UPMC, is a leader in developing cell-based therapies for a variety of conditions.

The institute’s research encompasses a broad array of disciplines including organ transplantation, diabetes, heart disease, and cancer. Utilizing adult stem cells derived from various sources, such as bone marrow and fat tissue, their pioneering efforts aim to regenerate damaged tissues and organs.